TCC1727
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TCC1727, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]